Cargando…
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects
PURPOSE: TPN171H is a novel, potent and selective phosphodiesterase type 5 (PDE5) inhibitor for the treatment of pulmonary arterial hypertension (PAH). The objective of this study was to evaluate the safety, tolerability, and pharmacokinetics of TPN171H in healthy subjects after single and multiple...
Autores principales: | Qian, Hongjie, Chen, Qian, Liang, Liyu, Zou, Yang, Pu, Huahua, Xin, Liang, Song, Rong, Li, Tingting, Zhu, Huijuan, Wang, Yu, Tian, Guanghui, Shen, Jingshan, Jiang, Hualiang, Yu, Chen, Wang, Zhen, Jia, Jingying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273902/ https://www.ncbi.nlm.nih.gov/pubmed/34262260 http://dx.doi.org/10.2147/DDDT.S308610 |
Ejemplares similares
-
A phase I study comparing the pharmacokinetics and safety of HS628 (tocilizumab biosimilar) and reference tocilizumab in healthy male subjects
por: Qian, Hongjie, et al.
Publicado: (2023) -
Extravasation of TPN following central venous catheter migration
por: Hong, SungMin, et al.
Publicado: (2022) -
Molecular Oxygen Levels and Percentages of DNA Damage in TPN Patients
por: Dąbrowska, Karolina, et al.
Publicado: (2023) -
Comparative study of the safety and efficacy of SMOFlipid vs non SMOFlipid as TPN for liver transplantation
por: Wu, Mei-Yun, et al.
Publicado: (2021) -
Bacillus velezensis ZN-S10 Reforms the Rhizosphere Microbial Community and Enhances Tomato Resistance to TPN
por: Chen, Enlei, et al.
Publicado: (2023)